RU2801151C1: Bovine brain protein–polypeptide hydrolysate process — RU2801151C1
N. V. Fedota, A. N. Shulunova, A. N. Kvochko · 2023 · RU2801151C1 · patent family RU2801151C1
Published 2023-08-02.
Reported patent results
Reported findings
Bovine brain hydrolysate manufacturing process with analytical and yeast-growth checks.
Applicant manufacturing examples and gel chromatography. The filing cites Cerebrolysat prior art.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Ninety-day rat tolerability series | 160 rats, four arms of 40. No adverse change in measured behavior, blood biochemistry or organ pathology was described. | Daily intramuscular 1.5, 15 or 150 mg/kg versus water control. Applicant-reported toxicology; underlying tables were not recovered. |
| Reported final protein–polypeptide concentration | 1.0–2.0 mg/mL | Preparation concentration, not a human dose. |
| Gel chromatographic characterization | Four fractions, reported 0.5–200 kDa range | Applicant analytical results. |
| Bioassay | Yeast-growth criterion at least 20% versus control | An assay threshold, not a measured human effect. |
A distinct patent-defined preparation. No verified equivalence to Cerebrolysat, Cortexin, PPC-M or PPK-V.
Source for the extracted data ↗ · Checked 2026-11-09
Patent claims and provenance
Manufacturing. Bovine brain hydrolysate manufacturing process with analytical and yeast-growth checks.
A distinct patent-defined preparation. No verified equivalence to Cerebrolysat, Cortexin, PPC-M or PPK-V.
- Publication
- RU2801151C1 ↗ · 2023-08-02
- Earliest priority / filing
- 2022-08-15 / 2022-08-15
- Original applicant / assignee
- Not established from accessed metadata
- Indexed status
- Not shown; official status unverified · checked 2026-11-09
- Patent family
- Grouping identifier unavailable · family publications are related filings, not independent studies.
Original title, inventors and related publications
Способ получения биологически активного белково-полипептидного гидролизата из тканей мозга
Inventors: N. V. Fedota; A. N. Shulunova; A. N. Kvochko.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- A distinct patent-defined preparation. No verified equivalence to Cerebrolysat, Cortexin, PPC-M or PPK-V.
- A distinct patent-defined preparation. No verified equivalence to Cerebrolysat, Cortexin, PPC-M or PPK-V.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-RU2801151C1. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-09. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: N. V. Fedota, A. N. Shulunova, A. N. Kvochko. RU2801151C1: Bovine brain protein–polypeptide hydrolysate process — RU2801151C1 RU2801151C1 · patent family RU2801151C1 2023.
Molekul research summary: https://molekul.io/research/patent-ru2801151c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry